1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : SPECIALTY PHARMACEUTICALS
  4. QUALIGEN THERAPEUTICS INC

Qualigen Therapeutics Inc

XNAS: QLGN

Download real time

3.13 -0.07 (-2.19%)

89.37% Fall from 52W High

407 XNAS Volume

XNAS 19 Mar, 2025 10:28 AM (EDT)

Watchlist

Portfolio

Share
6S
11W
1O
1T
2.3

Market Cap

Low in industry
-0.3

PE TTM

Negative PE TTM
0

PEG TTM

-1.1

Price to Book

Negative Price to Book
0.2

Beta 1Year

Very Low volatility


Insider Trading disclosures for Qualigen Therapeutics Inc

The latest disclosure was made by Tariq Arshad in Qualigen Therapeutics Inc where a trade of 102,000 Stock Option (Right to Buy) done was reported to US exchanges on July 11, 2022.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Tariq Arshad SVP/Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2022 102,000 102,000 - - Stock Option (Right to Buy)
Amy S. Broidrick Director, President/CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2022 130,000 130,000 - - Stock Option (Right to Buy)
Richard A. David Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2022 40,000 40,000 - - Stock Option (Right to Buy)
Wajdi Abdul-Ahad Vice President, R & D, CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2022 80,000 80,000 - - Stock Option (Right to Buy)
Shishir K. Sinha VP, COO & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2022 100,000 100,000 - - Stock Option (Right to Buy)
Christopher L. Lotz Vice President of Finance, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2022 100,000 100,000 - - Stock Option (Right to Buy)
Michael S. Poirier Director, Chairman and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2022 375,000 375,000 - - Stock Option (Right to Buy)
Matthew Korenberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2022 40,000 40,000 - - Stock Option (Right to Buy)
Ira E. Ritter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2022 40,000 40,000 - - Stock Option (Right to Buy)
Sidney W Emery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jul 2022 40,000 40,000 - - Stock Option (Right to Buy)
Michael S. Poirier Director, Chairman and CEO Purchase of securities on an exchange or from another person at price $ 0.57 per share. 22 Jun 2022 30,000 199,202 - 0.6 17,100 Common Stock
Amy S. Broidrick Director, President/CSO Purchase of securities on an exchange or from another person at price $ 0.62 per share. 14 Jun 2022 30,000 34,500 - 0.6 18,600 Common Stock
Amy S. Broidrick Director, President/ChiefStrategyOfficer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 300,000 300,000 - - Stock Option (Right to Buy)
Tariq Arshad SVP/Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 300,000 300,000 - - Stock Option (Right to Buy)
Tariq Arshad SVP/Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 May 2021 100,000 100,000 - - Stock Option (Right to Buy)
Amy S. Broidrick Director, EVP, Chief Strategy Officer Purchase of securities on an exchange or from another person at price $ 2.03 per share. 26 Apr 2021 4,500 4,500 - 2.0 9,135 Common Stock
Michael S. Poirier Director, Chairman, CEO & President Purchase of securities on an exchange or from another person at price $ 1.80 per share. 20 Apr 2021 11,005 11,005 - 1.8 19,809 Common Stock
Christopher L. Lotz Vice President of Finance, CFO Purchase of securities on an exchange or from another person at price $ 1.86 per share. 16 Apr 2021 2,700 12,541 - 1.9 5,022 Common Stock
Sidney W Emery Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2020 50,000 50,000 - - Stock Option (Right to Buy)
Amy S. Broidrick Director, Executive VP, CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2020 150,000 150,000 - - Stock Option (Right to Buy)
Kurt H. Kruger Director Purchase of securities on an exchange or from another person at price $ 3.55 per share. 20 Nov 2020 1,400 1,400 - 3.5 4,969 Common Stock
Kurt H. Kruger Director Purchase of securities on an exchange or from another person at price $ 3.46 per share. 20 Nov 2020 4,600 6,000 - 3.5 15,925 Common Stock
Amy S. Broidrick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Aug 2020 50,000 50,000 - - Stock Option (Right to Buy)
Richard A. David Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2020 50,000 50,000 - - Stock Option (Right to Buy)
Kurt H. Kruger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2020 50,000 50,000 - - Stock Option (Right to Buy)
Wajdi Abdul-Ahad Vice President, R & D, CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2020 500,000 500,000 - - Stock Option (Right to Buy)
Shishir K. Sinha Vice President of Operations Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2020 500,000 500,000 - - Stock Option (Right to Buy)
Christopher L. Lotz Vice President of Finance, CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2020 600,000 600,000 - - Stock Option (Right to Buy)
Michael S. Poirier Director, Chairman, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2020 1,000,000 1,000,000 - - Stock Option (Right to Buy)
Matthew Korenberg Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2020 50,000 50,000 - - Stock Option (Right to Buy)
Ira E. Ritter Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2020 50,000 50,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters